Jun 30, 2017

ANI Pharmaceuticals Q2 2017 Earnings Report

Total Revenue
$44.8M
Previous year: $31.3M
+42.9%
EPS
$0.98
Previous year: $1.11
-11.7%
Gross Profit
$23.6M
Previous year: $19.5M
+21.0%
Cash and Equivalents
$8.37M
Previous year: $15M
-44.3%
Free Cash Flow
-$2.3M
Previous year: $2.62M
-188.0%
Total Assets
$359M
Previous year: $308M
+16.6%

ANI Pharmaceuticals

ANI Pharmaceuticals